Stockscreener 앱 받기
3.11
8.36%
0.24
시간 외 거래:
3.17
0.06
+1.93%
전일 마감가:
$2.87
열려 있는:
$2.975
하루 거래량:
2.91M
Relative Volume:
1.04
시가총액:
$734.69M
수익:
$4.90M
순이익/손실:
$-399.99M
주가수익비율:
-1.0948
EPS:
-2.8407
순현금흐름:
$-122.90M
1주 성능:
-6.33%
1개월 성능:
-19.43%
6개월 성능:
-45.82%
1년 성능:
-43.14%
1일 변동 폭
$2.935
$3.18
1주일 범위
$2.82
$3.35
52주 변동 폭
$2.82
$7.9825
인벤티바 Stock (IVA) Company Profile
Compare IVA vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
3.11 | 734.69M | 4.90M | -399.99M | -122.90M | -2.8407 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
인벤티바 Stock (IVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2026-03-19 | 개시 | Truist | Buy |
| 2026-01-28 | 개시 | Barclays | Overweight |
| 2026-01-12 | 개시 | Leerink Partners | Outperform |
| 2026-01-07 | 재개 | UBS | Buy |
| 2025-11-06 | 개시 | Wolfe Research | Outperform |
| 2025-09-03 | 재개 | H.C. Wainwright | Buy |
| 2025-08-27 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | TD Cowen | Buy |
| 2024-11-12 | 개시 | UBS | Neutral |
| 2023-10-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-19 | 업그레이드 | Societe Generale | Sell → Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2022-11-15 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2021-03-08 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2020-08-05 | 개시 | ROTH Capital | Buy |
| 2020-08-04 | 개시 | Guggenheim | Buy |
| 2020-08-04 | 개시 | Stifel | Buy |
모두보기
인벤티바 주식(IVA)의 최신 뉴스
Inventiva S.A. (IVA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alpha Tau Medical Ltd. (DRTS) Stock Price & News - Syfe
ADARx Pharmaceuticals, Inc. (ADRX) Stock Price & News - Syfe
Inventiva Q2 Earnings Call Highlights - TradingView
Inventiva (IVA) held €166.1 million in cash but says its resources fall short of 12 months of needs. - Stock Titan
IVA - Finviz
CapEx per share of Inventiva SA ADR – HAM:6IVA - TradingView
6IVA Stock Price and Chart — HAM:6IVA - TradingView
6IVA Stock Price and Chart — HAM:6IVA - TradingView
VALN Stock Price, Quote & News - Syfe
IVA Price History for Inventiva S.A. ADR Stock - Barchart.com
Inventiva S.A.American Depository Shares Stock 12‑Month Price Target Cut to $14.35, Implies 212% Upside - TradingView
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Average Rating of "Buy" by Brokerages - MarketBeat
Inventiva (IVA) Slides 1.15% to $4.75 as Shares Approach Critical SupportVOLD Alert - careplusvn.com
Inventiva: MASH Is Becoming A Combination Market Before Lanifibranor Arrives (NASDAQ:IVA) - Seeking Alpha
Inventiva (IVA) Dips 2.5% as Biotech Sector Weighs on SentimentFund Manager Survey - careplusvn.com
Inventiva S.A. Sponsored ADR $IVA Stake Reduced by Ally Bridge Group NY LLC - MarketBeat
Inventiva (IVA) Dips 2.5% as Biotech Sector Weighs on SentimentMutual Fund Flow - dars.gov.et
Inventiva (IVA) Dips 2.5% as Biotech Sector Weighs on SentimentCalendar Spread Trade - www.dars.gov.et
Inventiva (IVA) Shares Edge Lower as Key Support Levels Come into FocusTriple EMA - careplusvn.com
Inventiva (IVA) Short Interest & Short Float | Updated Jul 2026 $IVA - MarketBeat
Inventiva (IVA) Gains Ground: Testing Resistance After Modest UptickTime Weighted Price - careplusvn.com
Inventiva (IVA) Gains 1.6% as Shares Test Key Resistance ZoneInvestment Factor - careplusvn.com
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Cantor Fitzgerald Initiates Inventiva SA ADR at Overweight - Moomoo
Cantor Fitzgerald Initiates Inventiva SA ADR at Overweight - Moomoo
Inventiva (IVA) Announces Issuance of New EIB Warrants, Completes EIB Warrant Restructuring - Yahoo Finance
After plunging 30.8% in 4 weeks, here's why the trend might reverse for Inventiva (IVA) - MSN
Inventiva (IVA) Gains 3.2% as Shares Test Key Resistance ZoneLow Volume Node - dars.gov.et
Inventiva S.A.American Depository Shares Stock 12‑Month Price Target Raised to $15.69, Implies 257% Upside - tradingview.com
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
6IVA Forecast — Price Target — Prediction for 2027 - TradingView
After plunging 30.8% in 4 weeks, here's why the trend might reverse for Inventiva (IVA) - MSN
Inventiva S.A. (IVA) is One of the Best Stocks Under $10 Offering More Than 50% Upside - Yahoo Finance
After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Inventiva (IVA) - Yahoo Finance
A2P796 Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (LSX:A2P796) - TradingView
6IVA Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (LS:A2P796) - TradingView
A2P796 Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (NASDAQ:IVA) - TradingView
6IVA Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (NASDAQ:IVA) - TradingView
Inventiva SA ADR Actuals & Estimates (NASDAQ:IVA) - TradingView
IVA News | INVENTIVA SAADR (NASDAQ:IVA) - ChartMill
Claret Capital Partners participates in €130m financing for Inventiva to support Phase 3 development - GlobeNewswire Inc.
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
Inventiva announces Repayment of EIB Loans, Repurchase of a portion of EIB Warrants and the Issuance of the first two tranches under New Debt Financing - GlobeNewswire Inc.
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
인벤티바 (IVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.22%
0.43%
자본화:
|
볼륨(24시간):